Magnus Financial Group LLC Capricor Therapeutics, Inc. Transaction History
Magnus Financial Group LLC
- $998 Million
- Q1 2025
A detailed history of Magnus Financial Group LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Magnus Financial Group LLC holds 20,000 shares of CAPR stock, worth $188,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$188,000
Previous $277,000
16.97%
% of portfolio
0.02%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
131Shares Held
15.9MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$21.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$21.2 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$20.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$15.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$8.27 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $229M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...